Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression

Prostaglandin E2, which is known to contribute to cancer progression, is inactivated by the catabolic enzyme, 15-hydroxyprostaglandin dehydrogenase (PGDH), which has tumor-suppressor activity in lung, colon, breast, and gastric cancers. Therefore, we evaluated the expression of PGDH in human bladder...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tseng-Rogenski, Stephanie, Gee, Jason, Ignatoski, Kathleen Woods, Kunju, Lakshmi P., Bucheit, Amanda, Kintner, Hallie J., Morris, David, Tallman, Christopher, Evron, Joshua, Wood, Christopher G., Grossman, H. Barton, Lee, Cheryl T., Liebert, Monica
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2010
Assuntos:
Regular Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2832165/
https://ncbi.nlm.nih.gov/pubmed/20093479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090875
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados